Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Diagnostic Tests Evaluated for Human Leptospirosis

By LabMedica International staff writers
Posted on 08 Aug 2013
The diagnosis of leptospirosis is often performed by the microscopic agglutination test (MAT) or by culture, but is confined to specialized laboratories.

Rapid Diagnostic Tests (RDTs) can be used for easy point-of-care diagnosis and three commercial kits have been evaluated for their diagnostic performance and compared with other standard assays. More...


Scientists at the Royal Tropical Institute (KIT; Amsterdam, The Netherlands) tested samples sent to their laboratory for leptospirosis diagnosis from July 2001 to August 2012. Blood, plasma, serum, and urine samples were cultured. The MAT was performed with a panel of live leptospires, and consisted of 16 strains of pathogenic serovars. An in-house enzyme-linked immunosorbent assay (ELISA) was developed for the detection of Leptospira-specific immunoglobulin M antibodies (IgM ELISA) and was performed with antigen prepared from the local strain Wijnberg (serovar Copenhageni, serogroup Icterohaemorrhagiae).

Three rapid diagnostic serological tests were used: Lepto Tek Dri Dot and Lepto Tek Lateral Flow (Organon Teknika B.V.; Boxtel, the Netherlands); and Leptocheck-WB, (Zephyr Biomedicals; Verna, Goa, India). Lepto Tek Lateral Flow and Leptocheck-WB are lateral flow immunochromatographic tests and LeptoTek Dri Dot is a latex agglutination assay and detects Leptospira-specific antibodies (IgM and IgG) in human sera.

The overall sensitivity for the LeptoTek Dri Dot was 75%, for the Lepto Tek Lateral, it was 78% Flow and 78% for the Leptocheck-WB. Specificity ranged from 95% to 98% in the three RDTs. Based on the first submitted sample the sensitivity was low, 51% for LeptoTek Dri Dot, 69% for Lepto Tek Lateral Flow, and 55% for Leptocheck-WB, but substantially increased when the results of paired samples were combined, although accompanied by a lower specificity, 82% for Lepto Tek Dri Dot, 86% for Lepto Tek Lateral Flow, and 80% for Leptocheck-WB.


The authors concluded that The LeptoTeK Lateral Flow presents in all scenarios with the best sensitivity and equally good specificity of all three RDT tests. All three tests, LeptoTek Dri Dot, LeptoTek Lateral Flow, and Leptocheck-WB present useful antibody tests contributing to the diagnosis of leptospirosis. However, since the overall sensitivity of the tested RDTs did not exceed 80%, one should be cautious to rely only on an RDT result, and confirmation by reference tests is strongly recommended. The study was published on July 11, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Dutch Royal Tropical Institute

Organon Teknika B.V

Zephyr Biomedicals



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.